Uveal Melanoma UK National Guidelines

Area of Science:

• Ophthalmology
• Oncology
• Medical Guidelines

Background:

• Uveal melanoma is a rare primary eye cancer.
• Key areas of uncertainty exist in its management, including prognostication, surveillance, and treatment of recurrence.

Purpose of the Study:

• To develop evidence-based guidelines for uveal melanoma management.
• To provide recommendations on new technologies for prognostication and treatment of hepatic recurrence.
• To define optimal surveillance pathways for patients post-treatment.

Main Methods:

• Systematic evidence review using the Scottish Intercollegiate Guidelines Network (SIGN) methodology.
• Development of recommendations by a UK guideline development group.
• International peer review and accreditation by NICE.

Main Results:

• Recommendations cover new prognostication technologies, patient surveillance post-primary treatment, and treatment of hepatic recurrence.
• Guidelines address the use and effectiveness of new technologies in treating hepatic recurrence.
• Recommendations also include the use of systemic treatments for uveal melanoma.

Conclusions:

• The guidelines offer a systematic, evidence-based approach to uveal melanoma management.
• Accreditation by NICE signifies the quality and reliability of the recommendations.
• These guidelines aim to standardize and improve care for uveal melanoma patients in the UK.